Mobile Health Apps and Solutions Market - Global Industry Analysis, Growth, Trends and Forecast to 2024

Mobile Health Apps and Solutions Market Overview

Proliferation of mobile devices provides an entirely new and effective dimension to the healthcare industry, wherein solutions can be provided to end users in an extremely easy-to-use manner that can be accessed irrespective of the use location. Advent of mHealth apps and solutions have led the healthcare solutions market to expand its reach from hospitals to primary care and office space.  The industry is witnessing influx of various start-ups venturing into the market, leading to high competition.

Mobile health apps segment is expected to grow at impressive double digit CAGR over the forecast period (2016–2024), creating new market opportunities for the players worldwide.

For More Information Request FREE Sample PDF Brochure : https://www.coherentmarketinsights.com/insight/request-sample/42

Proliferation of smartphones fueling mobile health apps and solutions market growth

Over 600 million people are expected to use mobile healthcare apps by 2017, creating a highly lucrative market opportunity for healthcare players. The industry is projected to be mainly driven by growing healthcare expenditure and consumer changing lifestyle. Advancements in computing ability of mobile devices would bridge the gap between patient’s expectation and treatment delivered. The technology is perceived to be an enabler of quality healthcare.

Though the industry is set to grow at a robust rate, lack of collaborations among healthcare service providers and low healthcare apps utilities awareness among the masses are major industry pitfalls.

Mobile Health Apps and Solutions Market Taxonomy:

Coherent Market Insights has segmented the mobile health apps and solutions market on the basis of following:

• ·         Operating System
• ·         Product Type
• ·         Therapeutic Application
• ·         Devices

On the basis of operating system, iOS mHealth app is expected dominated the market in 2015. However, the segment is expected to lose major market share to android app segment by 2024.

Among device segments, smartphones are expected to dominate the market, followed closely by tablets through 2024. Tablets are expected to be most prominent in developed regions.

Emergence of connected and integrated healthcare solutions driving growth of North America and Europe markets

The mobile health apps and solutions market report covers market analysis across regions namely North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Geographically, Europe, followed closely by North America is expected to dominate the market throughout the forecast period. Presence of leading mHealth service providers, along with wide availability of high-quality healthcare amenities, and increased healthcare awareness is expected to bolster market growth.

Request For Discount : https://www.coherentmarketinsights.com/insight/request-discount/42

The market in Asia Pacific is growing at the fastest rate, driven primarily by rising demand in China and India. China and India account for over 36% of global population, creating lucrative market opportunity for players in the long run.  Markets in Latin America, Middle East, and Africa are expected to grow at a relatively sluggish rate, with upward growth traction expected in the mid of the forecast period.

Mobile Health Apps and Solutions Market – Competitive Landscape

Major players in the mobile health apps and solutions market include Runtastic, Nike, MyFitnessPal, Azumio, GP Apps, Pacer Health, Kinosis, GoodRX, Leafly, and Epocrates.

ABOUT US

COMPANY OVERVIEW

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

Nano-silicon Drug Delivery Platform Market - Global Industry Analysis, Growth, Trends and Forecast to 2024

Safe and effective drug delivery is a major challenge against the pharmaceutical and biotechnology companies. Companies formulate their drugs in various dosage forms such as capsules, powders, inhalers, liquid, drops, tablets, transdermal patches, depot injection, and gels to address the drug delivery challenges in different conditions. Moreover, advancement in research has enabled controlled and sustained release of drugs to decrease the dosage and provide long term effect of the drug. Furthermore, new technologies such as nanotechnology and antibody-drug conjugate are being introduced to minimize cost and increase bioavailability. In all, there is all-together a new wave of innovation in life science sector that delivers medicines at the targeted site in right dose.

Enquiry Before Buying : https://www.coherentmarketinsights.com/insight/consult-us/45

Nanotechnology-based platforms are gaining significant importance in research and product development due to the enormous benefits they offer in terms of drug stability, bioavailability, dosage, and shelf-life.  Various types of nano-carriers or nanoparticles such as liposomes, magnetic particle, dendrimers, silver nanoparticle, silica nanoparticle, and polymeric micelles, carbon nanoparticles and drug-conjugate nanoparticles are used in different industries to cater the exact need or product.

SiSafe Nano-silicon Drug Delivery Platform                                                                               

SiSaf’s new drug delivery technology called SiSafe is a patented elemental nano-silicon porous structure with a massive surface area. A higher surface area provides high drug-loading capacity and thus significant increase in bioavailability of even the most hydrophobic compounds. So, a less soluble drug that needs to be injected directly in the bloodstream can have enhanced solubility through SiSafe nano-silicon platform. Molecules are incorporated within the nanopores, thus stabilizing the instable molecules and increasing the bioavailability of the drug. SiSafe is a biodegradable technology which enables customizing the rate of onset and release by altering the physical factors of the carriers such as linkage method, porosity, particle size, and pore width.

Get FREE Sample Of This Research Report At : https://www.coherentmarketinsights.com/insight/request-sample/45

Potential Applications

SiSafe will be of significant use to pharmaceutical, animal health, biotech and cosmeceutical companies to formulate and package drugs that are difficult to formulate otherwise. Companies finding better solutions for their existing drugs can incorporate this technology to improve their product quality. Also, new drugs used for chronic diseases can be delivered at a low dose to the target sites with the nano-silicon drug delivery platform.

This new nanotechnology-based drug delivery platform offers competitive advantages such as improved safety, efficacy, controlled release and desired time of onset of drug release. After years of research and development, and extensive capital investment, SiSafe nano-silicon drug delivery platform is ready for commercialization. SiSaf is looking to partner with drug developers who desire to improve their formulation with controlled releases and lower doses. SiSaf received a funding of USD 4.9 million from Singapore’s Vickers Venture Partners and Exen Capital recently in November 2016. This partnership is anticipated to be of great aid for SiSaf to reach more markets globally.

Browse Research Report At : https://www.coherentmarketinsights.com/ongoing-insight/nano-silicon-drug-delivery-platform-market-45

Nano-silicon Drug Delivery Platform to enable Low Cost Drug Delivery

Research for the use of nano-silicon particles in targeted tumor therapy is under progress. The study being conducted by various organizations globally including Tel Aviv University, Technion – Israel Institute of Technology in collaboration with Massachusetts Institute of Technology (MIT) and the Harvard Medical School are of the opinion that nano-silicon particles could deliver drugs over a long period of time, may be for weeks or even months. Such advancement in drug delivery technologies will revolutionize the pharmaceutical and biopharmaceutical drug industry by offering targeted drug therapies at a low cost.

ABOUT US

COMPANY OVERVIEW

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

Prosthetic Heart Valve Market - Global Industry Analysis, Growth, Trends and Forecast to 2024

Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where it does not provide relief to the patient, then surgery recommended as the best alternative to repair or replace the valve. In case of a valve replacement surgery, carbon based mechanical valves and biological tissue valve are the types of valves that can be selected based on the condition. Advancements in technology and increasing prevalence of heart valve diseases are some major factors projected to drive growth of the prosthetic heart valve market in the near future.

Get Free PDF Research Brochure for more Professional and Technical Insights : https://www.coherentmarketinsights.com/insight/request-sample/69

Selection of a Heart Valve also depends on the Type of Polymer

On the basis of product type, the global prosthetic heart valve market can be segmented into mechanical heart valves, transcatheter heart valves, and tissue heart valves. Tissue heart valves are harvested from pig heart valves and cow heart sac. The life of a tissue valve is 10 to 15 years. Tissue heart valves is further classified into stented tissue valve, stentless tissue valve, tissue-engineered valves, homograft valves, and heterograft valves. Aortic valves and mechanical mitral valves are the two types of mechanical heart valves.

Technologies for prosthetic heart valves include anti-calcification, sutureless valves, polymers, and carbon-based technologies. The primary cause of failure of bioprosthetic valves is structural valve deterioration due to tissue calcification. An anticalcification technology was developed that may irreversibly choke calcium binding sites in bioprosthetic valves. In February 2016, the U.S. FDA approved a new technology called sutureless aortic valve replacement that is used for treatment of aortic valve disease. Sutureless valves are used to treat aortic valve disease and is a relatively less invasive for patients. The use of polymers to produce leaflet valves, which have same benefit of bioprosthetic and mechanical valves has been available since mid-1950s. Much attention has been focused on thermoplastic polyurethanes due to its various beneficial properties.

Developed Nations Current Hubs, while Low and Middle Income Countries to emerge as Major Markets

Increasing prevalence of heart diseases, technological advancements, government funding, robust healthcare infrastructure, and rise in healthcare expenditure in the U.S. are major factors projected to propel growth of the prosthetic heart valve market in this region. According to Centers for Diseases Control and Prevention (CDC) about 610,000 people die due to heart diseases in U.S. every year.  The growth of prosthetic heart valve market in Asia is expected to be high in the near future due to increasing incidence of various chronic diseases and improving healthcare infrastructure in this region. According to a study published in the Lancet—a U.K.-based medical journal—the number of people affected by high blood pressure has almost doubled over past 40 years (from 1975 to 2015).

Get Discount Of This Report : https://www.coherentmarketinsights.com/insight/request-discount/69

Growing Aging Population highly susceptible to Heart Diseases to Spur growth of the prosthetic heart valve market

Advancements in technology, increasing aging population, and significant rise in prevalence of heart valve disorder are some factors that are expected to drive growth of the prosthetic heart valve market in the near future. However, factors such as high costs of development, stringent government regulations, reimbursement issues, and lack of trained professionals are inhibiting growth of the prosthetic heart valve market to certain extent.

Global players involved in the prosthetic heart valve market

The prosthetic heart valve market is characterized by the presence of major global players. Some of the prominent names include Boston Scientific Corporation, St. Jude Medical, Inc., Sorin S.P.A, Abbott Laboratories, Claret Medical, Inc., AorTech, Edwards Lifesciences Corporation, Neovasc Inc., and JenaValve Technology.

Better Patient Outcomes utilizing Prosthetic Heart Valves to Ensure Sustained Demand

Developed regions such as North America and Europe are rapidly growing regions in the prosthetic heart valve market, mainly attributed to robust healthcare infrastructure, increasing prevalence of valvular heart disease, and favorable reimbursement scenario. The experience of using an aortic bioprosthetic valve treated with anticalcification tissue technology demonstrates excellent valve performance, safety, and durability. Minimally invasive devices for treatment of heart surgery are the need of the hour to ensure better patient experience. The sutureless valve technology is less invasive for patients, which is expected to witness higher adoption in the near future. Transcatheter has given improved patient survival rate when compared with medical therapy.

ABOUT US

COMPANY OVERVIEW

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

CONTACT US

CORPORATE OFFICE:

Raj Shah

Coherent Market Insights
1001 4th Ave, 

# 3200         

Seattle, WA 98154

Tel:  +1-206-701-6702

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com/

Breast Pumps Market to surpass US$ 0.9 Billion by 2024 : Coherent Market Insights

The Global Breast Pumps Market was valued at US$ 606.6 million in 2015 and is projected to expand at a CAGR of 4.8% during 2016–2024, according to a new report published by Coherent Market Insights. Rapidly growing population and improving insurance scenario is propelling demand for breast pumps worldwide.

Demand for electronic breast pumps is gaining high traction in terms mainly due to adjustable suction level aiding ease of use. A more recent trend is the growing rental market for these pumps, as it is a cost-effective option for working women in most developing countries. A battery-powered pump further increases the convenience for women on-the-go who cannot find an electrical source for operating the electric pump. However, most women, especially in emerging economies such as India do not have insurance and thus, prefer the more feasible option of manual pumps. This scenario is changing rapidly, with higher disposable income in these regions inclining women towards more effective electric breast pumps.

Get Free PDF Research Brochure for more Professional and Technical Insights : https://www.coherentmarketinsights.com/insight/request-sample/81

Closed breast pump systems are more secure and offer a higher safety element, which in turn increases its demand in the market. Moreover, closed breast pumps can be used multiple times and for longer period as compared to open breast pumps, resulting in higher cost saving. To enhance the comfort and convenience in expressing milk, Naya Health, Inc. introduced a smart breast pump in December 2016. This smart breast pump, based on water pumping technology, connects the pump to the Naya Health Tracker app, which helps the mother control the machine and track the amount of milk expressed and consumed by the baby, thus effectively managing nursing sessions. The first smart breast pump launched by Medela AG in November 2016 is aimed at providing nursing mothers access to expert tips and clinically proven support.

According to the U.S. Department of Labor (DOL), around 57% of women were part of the active workforce in the U.S. in 2015. The DOL projects that by 2024, women in the age group of 25 to 34 years would constitute major share of employed women in the U.S. These factors are projected to collectively spurt growth of breast pumps market in the U.S. over the following decade.

As per the Australian Bureau of Statistics, women constitute 46.2% of total workforce in Australia as of August 2016. According to the 2015 report from International Monetary Fund, gender gap in workforce is the highest (51 percentage points) in the Middle East and North Africa. Societal factors in certain emerging economies such as India, Pakistan, and Nepal play a major role in the lower percentage of women in the workforce in these countries. Moreover, awareness levels regarding breast pumps in these regions is relatively low.  These are the major restraining factors for growth of the breast pumps market in Asia and Africa.

  

Key takeaways of the market:

·         The global breast pumps market is expected to expand at a CAGR of 4.8% during the forecast period (2016 – 2024). Factors attributable to market growth include increasing number of women in the workforce, growing disposable income, and favorable reimbursement policies.

·         Demand for closed-system is significantly high owing to low risk of infection and possibility of repeated use with longer life-span as compared to the open-system

·         The total market for manual pumps was valued at US$ 340.6 mn in 2015. Demand for manual breast pumps is high among low income groups, mainly due to low insurance coverage.

·         Single-electric breast pumps segment is projected to witness growth higher than that of the overall market, at a CAGR of 5.9% during the forecast period. Factors attributable to the positive growth of this segment includes ease and convenience in expressing breast milk and reimbursement by insurance companies, especially in the U.S.

·         Medela AG and Naya Health Inc. are among the leading players in the global breast pumps market. Major players constantly work towards introducing innovate products and focus on geographical diversification in order to further strengthen their position in the market.

Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/81

ABOUT US

COMPANY OVERVIEW

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

CONTACT US

CORPORATE OFFICE:

Raj Shah

Coherent Market Insights
1001 4th Ave, 

# 3200         

Seattle, WA 98154

Tel:  +1-206-701-6702

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com/

3D Printing for Medical Sector Market to Surpass US$ 1.1 Billion by 2024

3D Printing for Medical Sector Market

The Global 3D Printing for Medical Sector Market is projected to reach US$ 1,109.2 million by 2024 experiencing market growth at a CAGR of 11.7% from 2016 to 2024, according to a new report published by Coherent Market Insights. 3D printing has revolutionized the way medical procedures are performed, medical training is provided, and cost-effective medical products are being developed. Improved clinical outcomes is attracting the medical community to explore various avenue of 3D printing in the medical sector.

Get FREE Sample Of 3D Printing for Medical Sector Market Report, Here : https://www.coherentmarketinsights.com/insight/request-sample/80

3D printing has been around since 1984. However, until recent advancements in technology which attracted people’s attention, 3D printing also gained traction for applications in healthcare. This includes development of surgical implants, biological prototypes, artificial organs, and dental implants. Innovation in 3D printing technology is expected to drive down healthcare costs much lower than current levels and increase medical product accessibility. Also, increasing demand for personalized medicines, and reduction in manufacturing cost and time would propel demand for 3D printed medical products in the near future. Wiiv—a Vancouver-based startup—uses 3D printing technology to create customized insoles for patients suffering from joint discomfort, plantar fasciitis pain, and general foot fatigue.

3D printing is a disruptive technology for conventional manufacturing process that involve major input costs, time, high amount of waste, and high error rate. This is owing to the fact that 3D printing involves layer by layer printing which eliminates waste generation and allows error-free process. Furthermore, the polygel technology enables producing product or device in desired color utilizing different materials.

3D printing in the medical sector has gained significant success in the dental and orthopedic implant segments. Currently, there is inadequate reimbursement for dental procedures in the U.S. 3D printed dental implants and products would lower the cost of dental procedures, making it more affordable and accessible to patients.

Various technologies such as electron beam melting, laser beam melting, photo polymerization, droplet deposition, and laminated object manufacturing are implemented in 3D printing of healthcare products. These technologies are gradually evolving with increasing knowledge about 3D printing products and demand for innovative and personalized medical products. However, clarity on regulatory aspects on manufacturing and approval process of 3D printed products is sought for the technology to be implemented on a large scale. This would also enable pharmaceutical and medical device manufacturers to focus on development of innovative healthcare products at low costs without compromising on profit margins.

Despite significant advantages of this technology, 3D printing for medical sector technology is facing challenge in terms of high installation cost of the machine in order to achieve desired operational efficiency. Moreover, lack of trained professionals is also acting as a key challenge for its adoption. However, with the focus on introducing cost effective products, pharmaceutical and medical device manufacturers are expected to invest a huge amount of capital in research and development related to 3D printing.

  

Key takeaways of the market:

·         The droplet deposition technology is a principle technology used in 3D printing primarily due to high heat and chemical durability. This technology segment held a market share of around 35% (in terms of revenue) in 2015.

·         The surgical implants application segment dominated the market in 2015, value of US$ 265.0 million. Large pool of patients suffering from dental issues, cardiovascular, metabolic and bone disorders, is attributable to this dominant market value.

·         Currently, 3D printing is highly used in the academic and research institutes for creating 3D printed biological models which are used for training and pre-operative preparation purpose

·         In 2015, North America dominated the global 3D printing for medical sector market (in terms of revenue) owing to favorable government policies for 3D printing and also rapid adoption of 3D printing in improving health outcomes. However, demand for 3D printing for medical application is expected to increase rapidly in the Asia Pacific region owing to favorable government policies propelling investments and use of 3D printing in medical sector For instance, Shanghai Children's Medical Center opened China’s first pediatric-specific 3D printing medical research unit in 2015. Furthermore, Chinese government, in July 2016, announced the establishment of its first 3D printing factory specifically for medical products in Chongqing, Southwest China.

Market players are collaborating for conducting research and developing 3D printed products at affordable price. Johnson & Johnson collaborated with Organovo in January 2016 to study the viability of bioprinted human tissue in testing new drugs. Also, Stratasys, Inc. partnered with a New York-based Jacobs Institute in April 2016 to establish a new Center of Excellence (COE) at the institute. This COE will be aimed at using 3D printing to develop and assess new medical devices and promote clinical education and training.

ABOUT US

COMPANY OVERVIEW

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

CONTACT US

Raj Shah

Coherent Market Insights
1001 4th Ave, 

#3200          

Seattle, WA 98154

Tel:  +1-206-701-6702

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com/

Visit Blog : http://globalresearchtrends.blogspot.in/

Life Sciences BPO Market to reach US$ 505 Billion by 2024 : Coherent Market Insights

The Global Life Sciences BPO Market was valued US$ 180.4 billion in 2015 and is projected to reach US$ 505.0 billion by 2024, according to a new report published by Coherent Market Insights. Reducing cost and increasing focus on core strengths is influencing medical device and pharmaceutical companies to outsource their processes to contract manufacturing organizations (CMO) and contract research organizations (CRO).

Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/24

Increasing demand for low cost drugs, rising cost pressure from various governments, patent cliffs, and uncertain regulatory conditions are factors contributing to increasing revenue growth of the global life sciences BPO market. Globally, pharmaceutical, and medical device companies are entering into strategic agreements with contract research organizations to leverage their expertise. This is helping them introduce new products at reduced costs and in turn obtain a competitive advantage.

In the current market scenario, outsourcing service is extended to medical coding, medical transcription, and clinical services. CMO and CROs provide products and services at much lower costs. Moreover, their regional regulatory expertise helps pharmaceutical and medical device companies to meet regulatory requirements in various countries.

Demand for life sciences BPO is high in Asia and Latin America due to large patient pool, easy availability of patients for clinical studies at a lower cost, and cost effective CMOs and CRO services. However, rising concerns over U.S. Food and Drug Administration (FDA) inspections in these regions is adversely impacting market growth to a certain extent. CMOs and CROs such as Divis Laboratories Ltd., Accenture pl., and PAREXEL International Corporation are investing to cater to demand for Good Manufacturing Practices (GMP) requirements and regain the trust and share for CMO and CRO market.

To know the latest trends and insights of this market, click the link below:

http://www.coherentmarketinsights.com/market-insight/life-sciences-bpo-market-24

Key takeaways of the market:

·         Constant endeavor for achieving high-quality results at low cost is driving demand for outsourcing in the global healthcare industry. This trend is expected to propel the global life science BPO market at a compound annual growth rate (CAGR) of 12.2% during the forecast period.

·         Pharmaceuticals outsourcing segment led the global life sciences BPO market with an estimated value of US$ 119.6 billion in 2015. Larger number of players are involved in contract manufacturing of pharmaceuticals and biotech products as compared to that of medical devices. In terms of medical devices, a contract manufacturer turns out to be the long-term manufacturer for that particular device. Pharmaceutical companies on the other hand, have cost-based contracts with CMO, as shifting to other vendors (CMOs) is easy due to presence of large number of contract manufacturers worldwide.

·         In terms of end users, healthcare providers dominate the market and accounted for a share of 89.1% in 2015. Healthcare providers which include manufacturers, and research organizations are using these services in order to streamline their process, and focus on core business.

·         Currently, market players such as Accenture plc. Cognizant Technology Solutions, Catalent, Inc., Covance, Inc., Boehringer Ingelheim GmbH and Genpact Limited are offering a plethora of service as a one-stop solution to healthcare providers to outsource their processes.

Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/24

ABOUT US

COMPANY OVERVIEW

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

CONTACT US

CORPORATE OFFICE:

Coherent Market Insights
1001 4th Ave, 

#3200          

Seattle, WA 98154

Tel:  +1-206-701-6702

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com/

Interventional Neurology Market to surpass US$ 2.7 Billion by 2024 : Coherent Market Insights

1. Interventional Neurology Market

The Global Interventional Neurology Market is projected to reach USD 2,684.6 million by 2024, according to a new report by published by Coherent Market Insights. Recommendations from the American Heart Association and American Stroke Association to use neurointerventional devices in stroke is a major factor boosting market growth.

Increasing demand for minimally invasive procedures is one of the prime factors driving adoption of neurointerventional devices worldwide. The American Heart Association and American Stroke Association recommends use of neurointerventional devices in treating stroke, due to which there has been an augmented demand for these devices in the recent past. In order to capitalize on this highly lucrative growth opportunity, a range of new products such as Solitaire stent retriever, EmboTrap stent retriever, and Penumbra 3D Revascularization Device have been launched in the recent past.

For Any Queries Get Solutions With A FREE PDF Sample : https://www.coherentmarketinsights.com/insight/request-sample/56

Developed economies such as the U.S., Canada, U.K., Australia, Japan, and Germany are witnessing rapid shift from conventional surgical methods to minimally invasive therapies. Moreover, there is a shift towards adopting detachable and bare platinum coils as against the highly priced coated coils. According to the Brain Aneurysm Foundation, around six million people in the U.S. i.e. one in 50 people suffer from brain aneurysm every year. High incidence rate of stroke and aneurysm is expected to continue strengthening demand for neurointerventional devices in the U.S. market.

The global Interventional neurology market is witnessing strategic agreements among leading players focusing on diversifying their product portfolio and increasing their market presence.

·         In 2016, Codman & Shurtleff, Inc. inked an exclusive distribution agreement with InNeuroCo, Inc. for its intermediate catheter and super distal access device in the U.S. and European markets

·         In 2015, Medtronic PLC acquired Lazarus Effect, a California-based medical device company engaged in development of acute ischemic stroke products for around US$ 100 million. Lazarus Effect was acquired with an aim to enhance Medtronic’s neurovascular business and related portfolio.

Advent of innovative solutions that enhance the outcomes of surgeries are fueling demand for neurointerventional devices

·         Medical University of South Carolina (MUSC) is investigating the safety and success rate of ADAPT - direct-aspiration first pass technique that removes the clot in a single-pass

·         FDA expanded the approval of Solitaire stent retriever device of Medtronic PLC for reduction of stroke-related disability. This device can now be used in patients with large vessel occlusion, proximal anterior circulation, and smaller core infarcts to reduce paralysis, and other stroke-related disabilities.

·         CE approved EmboTrap stent retriever platform, the EmboTrap II Revascularization Device from Neuravi Ltd. This new device enables removal of clots of different lengths with ease.

To know the latest trends and insights of this market, click the following link:

http://www.coherentmarketinsights.com/market-insight/interventional-neurology-market-56

Key takeaways of the market include:

·         There are a range of neurointerventional devices such as embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy devices, embolic protection devices, and flow diverter devices available in the market. Embolic coils was the largest segment and accounted for 32.5% share (in terms of revenue) in 2015. This is mainly due to these being the mainstay of endovascular treatment for brain aneurysms and hemorrhage.

·         Demand for stent retrievers is anticipated to grow at a rapid pace during the forecast period (2016 – 2024). This is mainly attributed to these being used as a one-step technique for device deployment and clot retrieval. The launch of this device in Japan is anticipated to also contribute towards the market growth in Asia Pacific.

·         Introduction of new techniques such as flow disruption and ADAPT aspiration technique is expected reduce the revenue share of coiling technique segment, and is projected to account 34.3% of the total market revenue by 2024

·         Demand for neurointerventional devices is analyzed to be high in hospitals as compared to ambulatory centers, due to growing number of surgical procedures in hospitals. The hospitals end use segment is analyzed to expand at a CAGR of 5.2% during the forecast period.

·         In 2015, North America dominated the global Interventional neurology market, with the contribution of the region estimated at US$ 701.9 million. Increasing incidence rate of brain aneurysm and ischemic strokes along with favorable government policies such as Medicare and Medicaid is expected to bolster sales of interventional neurology devices over the forecast period.

·         Growing focus on introducing technological advanced devices is expected to drive market growth in the long run

o   Stryker Corporation’s subsidiary Concentric Medical’s Trevo XP ProVue Retriever received FDA approval for its use in strokes in November 2016

o   Penumbra 3D Revascularization Device Trial successfully met the primary trial endpoints in 2016

Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/56

ABOUT US

COMPANY OVERVIEW

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

CONTACT US

Raj Shah

Coherent Market Insights
1001 4th Ave, 

#3200          

Seattle, WA 98154

Tel:  +1-206-701-6702

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com/

Visit Blog : http://globalresearchtrends.blogspot.in/